4
Changes in Ownership
Verrica Pharmaceuticals Inc. Filed Acc 0001209191-23-043304
Chief Medical Officer sold 28,699 shares at $4.83 ($138,616)
- Chief Medical Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Goldenberg Gary · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-21 | Grant or award : show line 1 in the form | +75,000 | 98,809 | D | ||
| 2023-07-24 | Sale : show line 2 in the form | −28,699 | $4.83 | $138,616 | 70,110 | D |
| Open-market sales · 28,699 sh · avg $4.83 · $138,616 | ||||||
Loading xslF345X05/doc4.xml…